Medicare Reform Prospects Beginning To Fade – CMS Administrator Scully
This article was originally published in The Gray Sheet
Executive Summary
CMS Administrator Tom Scully is no longer confident that the Medicare reform conference committee will be able to agree on a final product, let alone produce a bill that can pass both chambers
You may also be interested in...
DME competitive bidding momentum
One-year freeze on durable medical equipment spending, followed by competitive bidding implementation, likely will be included in the final Medicare reform package, according to device stakeholders. The new technology provisions also are coming under scrutiny, as conferees look to keep the "Medicare Prescription Drug & Modernization Act" of 2003 (HR 1, S 1) under the $400 bil. figure proposed by President Bush. Working with lawmakers, AdvaMed has succeeded in reducing the new tech score to $1.5 bil., but conferees may try to lower the amount to $1 bil. or less...
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.
Pair Of Deaths Linked To Recalled Vyaire Medical Respiratory Devices
The US FDA has labelled a recall of more than 6 million Airlife respiratory support devices class I. The recall covers devices manufactured in 2017 or earlier that can fail to provide adequate ventilation.